From Signal to Certainty: Why COPD Needs More Than One Trial
{{output}}
The U.S. Food and Drug Administration's proposal to adopt a single randomized controlled trial (RCT) as the default evidentiary standard for drug approval marks a substantial change in regulatory philosophy. Although advances in mechanistic science, biomarker... ...
